Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

Co-hosted by Veronica Green, the aim was to bring attention to the importance of communicating both symptoms and feelings ...

In true form, BIO-Europe will mark its 30th anniversary in Stockholm, Sweden, from November 4-6, 2024. The Nordic region ...

Now, the FDA has added three new products to its list of medicines in short supply as a result of the plant being taken ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...